Skip to main content

A Ph. 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Safety & Efficacy of Evening-dosed HLD200, a Novel Delayed & ER Formulation (DELEXIS) of Methylphenidate Hydrochloride, on Post waking, Early Mor

Clinical Trial Grant
Duke Scholars

Administered By

Psychiatry & Behavioral Sciences

Awarded By

Ironshore Pharmaceuticals & Development, Inc

Start Date

December 15, 2015

End Date

December 14, 2016
 

Administered By

Psychiatry & Behavioral Sciences

Awarded By

Ironshore Pharmaceuticals & Development, Inc

Start Date

December 15, 2015

End Date

December 14, 2016